Neurogastroenterology and Motility

Article	Citations
Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0©	576
What is new in Chicago Classification version 4.0?	85
ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease	84
Body surface mapping of the stomach: New directions for clinically evaluating gastric electrical activity	70
Chicago classification version 4.0© technical review: Update on standard high‐resolution manometry protocol for the assessment of esophageal motility	51
Implications of SARS‐CoV‐2 infection for neurogastroenterology	47
Evidence for the presence and release of BDNF in the neuronal and non‐neuronal structures of the internal anal sphincter	47
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome	43
Esophagogastric junction outflow obstruction	43
Chicago Classification update (V4.0): Technical review on diagnostic criteria for ineffective esophageal motility and absent contractility	43
Functional gastrointestinal and somatoform symptoms five months after SARS‐CoV‐2 infection: A controlled cohort study	40
Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation	39
Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems	39
Postoperative ileus—An ongoing conundrum	38
Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome	37
Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry	36
Evaluating esophageal motility beyond primary peristalsis: Assessing esophagogastric junction opening mechanics and secondary peristalsis in patients with normal manometry	36
Standardized system and App for continuous patient symptom logging in gastroduodenal disorders: Design, implementation, and validation	35
Deconstructing stigma as a barrier to treating DGBI: Lessons for clinicians	35
Principles and clinical methods of body surface gastric mapping: Technical review	33
Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register‐based pathology cohort	33
A novel scalable electrode array and system for non‐invasively assessing gastric function using flexible electronics	32
Current status of fecal microbiota transplantation for irritable bowel syndrome	32
Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome	32
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	31

Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID‐19	31
Increased prevalence of gastrointestinal symptoms and disorders of gut‐brain interaction during the COVID‐19 pandemic: An internet‐based survey	30
Review of the indications, methods, and clinical utility of anorectal manometry and the rectal balloon expulsion test	29
The effect of chronic nausea on gastric slow wave spatiotemporal dynamics in children	28
Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations	28
An automated artifact detection and rejection system for body surface gastric mapping	28
Chicago Classification update (v4.0): Technical review of high‐resolution manometry metrics for EGJ barrier function	27
Clinical associations of functional dyspepsia with gastric dysrhythmia on electrogastrography: A comprehensive systematic review and meta‐analysis	27
Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment	26
Eating disorder symptoms, including avoidant/restrictive food intake disorder, in patients with disorders of gut‐brain interaction	26
Anti‐inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction	26
Exploring joint patterns of brain structure and function in inflammatory bowel diseases using multimodal data fusion	26
Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non‐erosive reflux disease	26
Esophageal pH increments associated with post‐reflux swallow‐induced peristaltic waves show the occurrence and relevance of esophago‐salivary reflex in clinical setting	25
Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome	25
Prevalence of disordered eating in adults with gastrointestinal disorders: A systematic review	25
Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease	25
Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome	24
Narrative review: Risk of eating disorders and nutritional deficiencies with dietary therapies for irritable bowel syndrome	24
Gastrointestinal symptoms and the severity of COVID‐19: Disorders of gut–brain interaction are an outcome	24
Revised spectral metrics for body surface measurements of gastric electrophysiology	22
Chicago Classification Update (v4.0): Technical review on diagnostic criteria for hypercontractile esophagus	22
Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents with functional abdominal pain disorders	21
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	21
Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria	21
Chicago Classification update (version 4.0): Technical review on diagnostic criteria for achalasia	19
Factors that contribute to the impairment of quality of life in gastroparesis	19
Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation	19
Gastric accommodation: Physiology, diagnostic modalities, clinical relevance, and therapies	19
Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation	19
Mechanisms underlying the promotion of 5‐hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus	18
Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach	18
The inability to belch syndrome: A study using concurrent high‐resolution manometry and impedance monitoring	18
Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease	18
European Society for Neurogastroenterology and Motility (ESNM) recommendations for the use of high‐resolution manometry of the esophagus	17
Cardiac autonomic regulation and joint hypermobility in adolescents with functional abdominal pain disorders	17
Transcutaneous vagal nerve stimulation protects against stress‐induced intestinal barrier dysfunction in healthy adults	17
Impact of COVID‐19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress	17
Chicago Classification Update (v4.0): Technical review on diagnostic criteria for distal esophageal spasm	17
Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome	17
Bile Acid Diarrhea in Adults and Adolescents	17
Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia	17
Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome	16
Autoimmune and viral risk factors are associated with achalasia: A case‐control study	16
Long‐term personalized low FODMAP diet in IBS	16
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo	16
Greater intolerance to uncertainty predicts poorer quality of life in adults with cyclic vomiting syndrome	16
The not‐so‐rare absent RAIR: Internal anal sphincter achalasia in a review of 1072 children with constipation undergoing high‐resolution anorectal manometry	15
Retrograde upper esophageal sphincter function… and dysfunction	15
Herbal medicines in functional dyspepsia—Untapped opportunities not without risks	14

Racial disparity in healthcare utilization among patients with Irritable Bowel Syndrome: results from a multicenter cohort	14
Effects of pharmacological agents for neurogenic oropharyngeal dysphagia: A systematic review and meta‐analysis	14
Role of the duodenal microbiota in functional dyspepsia	14
Luminal short‐chain fatty acids and 5‐HT acutely activate myenteric neurons in the mouse proximal colon	14
A multicenter study of anorectal pressures and rectal sensation measured with portable manometry in healthy women and men	14
Mental distress among adult patients with eosinophilic esophagitis	14
Functional anorectal studies in patients with low anterior resection syndrome	14
Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers	14
Fasting pyloric diameter and distensibility by functional endoluminal imaging probe in unsedated healthy volunteers	13
Effect of amino acid‐based formula added to four‐food elimination in adult eosinophilic esophagitis patients: A randomized clinical trial	13
Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes	13
Diagnostic and clinical utility of the wireless motility capsule in children: A study in patients with functional gastrointestinal disorders	13
Randomized controlled trial of home biofeedback therapy versus office biofeedback therapy for fecal incontinence	13
Duodenal eosinophilia and the link to anxiety: A population‐based endoscopic study	13
Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID‐19 pandemic	13
Protective effects of Crataegus azarolus L. berries aqueous extract against castor oil–induced diarrhea, oxidative stress, and inflammation in rat	13
The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic	12
Prokinetic actions of luminally acting 5‐HT4 receptor agonists	12
Altered gene expression signatures by calcitonin gene‐related peptide promoted mast cell activity in the colon of stress‐induced visceral hyperalgesia mice	12
A putative anti‐inflammatory role for TRPM8 in irritable bowel syndrome—An exploratory study	12
Using high resolution manometry impedance to diagnose upper esophageal sphincter and pharyngeal motor disorders	12
Gastric sensorimotor function and its clinical measurement	12
Smartphone app‐delivered gut‐directed hypnotherapy improves symptoms of self‐reported irritable bowel syndrome: A retrospective evaluation	12
Changes in intestinal barrier protein expression and intestinal flora in a rat model of visceral hypersensitivity	12
A novelMRI‐based three‐dimensional model of stomach volume, surface area, and geometry in response to gastric filling and emptying	12
Aging of enteric neuromuscular systems in gastrointestinal tract	12
Role of psychological questionnaires in clinical practice and research within functional gastrointestinal disorders	12
Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux	12
Anorectal manometry to diagnose dyssynergic defecation: Systematic review and meta‐analysis of diagnostic test accuracy	12
An integrative healthcare model with heartfulness meditation and care coordination improves outcomes in cyclic vomiting syndrome	12
Non‐uniform gastric wall kinematics revealed by 4D Cine magnetic resonance imaging in humans	12
Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue	12
Low FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: An open‐labeled randomized trial	12
Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis	11
Autoimmune gastrointestinal dysmotility following SARS‐CoV‐2 infection successfully treated with intravenous immunoglobulin	11
Gastric function in diabetic gastroparesis assessed by ultrasound and scintigraphy	11
Development of quality indicators for the diagnosis and management of achalasia	11
Relationship between symptoms during a gastric emptying study, daily symptoms and quality of life in patients with diabetes mellitus	11
Neurons populating the rectal extrinsic nerves in humans express neuronal and Schwann cell markers	11
Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome	11
Assessment of pyloric sphincter distensibility and pressure in patients with diabetic gastroparesis	11
Quercetin relaxes human gastric smooth muscles directly through ATP‐sensitive potassium channels and not depending on the nitric oxide pathway	11
Targeting the pylorus in gastroparesis: From physiology to endoscopic pyloromyotomy	11
Normative values for esophageal functional lumen imaging probe measurements: A meta‐analysis	11
Effect of slow, deep breathing on visceral pain perception and its underlying psychophysiological mechanisms	11
Symptom severity and clinical characteristics of patients with bloating	11
What elements in the physician‐patient relationship (PPR) contribute to patient satisfaction: Development of a short form PPRS‐Patient Version (PPRS‐Patient SF) Questionnaire	11
Motor patterns in the proximal and distal mouse colon which underlie formation and propulsion of feces	11
Enhancing the utility of antroduodenal manometry in pediatric intestinal pseudo‐obstruction	10
Chronic opioid use is associated with obstructive and spastic disorders in the esophagus	10
History of trying exclusion diets and association with avoidant/restrictive food intake disorder in neurogastroenterology patients: A retrospective chart review	10
Reflux characteristics triggering post‐reflux swallow‐induced peristaltic wave (PSPW) in patients with GERD symptoms	10
Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research	10
Retrograde slow‐wave activation: a missing link in gastric dysfunction?	10
Variables influencing manometric parameters of deglutitive and non‐deglutitive upper esophageal sphincter: A study of 89 asymptomatic participants	10
Diagnostic yield of adding solid food swallows during high‐resolution manometry in esophageal motility disorders	10
Early adverse life events and post‐traumatic stress disorder in patients with constipation and suspected disordered defecation	10
High‐resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: An acute, open label, randomized, crossover, reader‐blin	10
Auricular vagal nerve stimulation enhances gastrointestinal motility and improves interstitial cells of Cajal in rats treated with loperamide	10
Digital health for functional gastrointestinal disorders	10
Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome	10
Effect of intestinal microbiota transplantation on cerebral ischemia reperfusion injury in aged mice via inhibition of IL‐17	10
Role of enteric dopaminergic neurons in regulating peristalsis of rat proximal colon	10
Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities	10
How big is the little brain in the gut? Neuronal numbers in the enteric nervous system of mice, Guinea pig, and human	10
Colonic 5‐HT4 receptors are targets for novel prokinetic drugs	10
Intrinsic cholinergic innervation in the human sigmoid colon revealed using CLARITY, three‐dimensional (3D) imaging, and a novel anti‐human peripheral choline acetyltransferase (hpChAT) antiserum	10
Automatic assessment of human gastric motility and emptying from dynamic 3D magnetic resonance imaging	10
Epidemiology of disorders of Gut‐Brain interaction in Israel: Results from the Rome Foundation global epidemiology study	9
Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson’s disease	9
Dysphagia Screening in Parkinson's Disease. A diagnostic accuracy cross‐sectional study investigating the applicability of the Gugging Swallowing Screen (GUSS)	9
Artificial intelligence facilitates measuring reflux episodes and postreflux swallow‐induced peristaltic wave index from impedance‐pH studies in patients with reflux disease	9
From Chicago classification v3.0 to v4.0: Diagnostic changes and clinical implications	9
Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination	9
High‐resolution impedance manometry characterizes the functional role of distal colonic motility in gas transit	9
Quantification of gastric emptying with magnetic resonance imaging in healthy volunteers: A systematic review	9
Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities	9
Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: Relationships to symptoms of gastroparesis	9
Codeine induces increased resistance at the esophagogastric junction but has no effect on motility and bolus flow in the pharynx and upper esophageal sphincter in healthy volunteers: A randomized, dou	9
Psychometric evaluation of an experience sampling method–based patient‐reported outcome measure in functional dyspepsia	9

Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories	9
Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐es	9
Health‐care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis	9
Prevalence and beverage‐related risk factors of gastroesophageal reflux disease: An original study in Chinese college freshmen, a systemic review and meta‐analysis	9
Dopamine and ghrelin receptor co‐expression and interaction in the spinal defecation centers	9
Oxidized phospholipids affect small intestine neuromuscular transmission and serotonergic pathways in juvenile mice	9
Analysis of contractile segment impedance during straight leg raise maneuver using high‐resolution impedance manometry increases diagnostic yield in reflux disease	9
Gastric half emptying time (T½) for 4‐h gastric emptying scintigraphy simplifies reporting but reduces detection of gastroparesis	9
Propagation patterns of jejunal motor activity measured by high‐resolution water‐perfused manometry	9
The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health	9
Behavioral therapy is superior to follow‐up without intervention in patients with supragastric belching—A randomized study	9
The edible Lactobacillus paracasei X11 with Konjac glucomannan promotes intestinal motility in zebrafish	9
Tight junction proteins in the small intestine and prefrontal cortex of female rats exposed to stress of chronic isolation starting early in life	9
A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross‐disease analyses	9
Episode‐level reflux characteristics: How experienced reviewers differentiate true reflux from artifact on pH‐impedance studies	9
Mucosal eosinophils, mast cells, and intraepithelial lymphocytes in youth with rumination syndrome	8
A double‐blind randomized, multicenter, placebo‐controlled study of itopride in functional dyspepsia postprandial distress syndrome	8
Effect of colonic distension on small bowel motility measured by jejunal high‐resolution manometry	8
Reference high‐resolution manometry values after magnetic sphincter augmentation	8
A comparison of rectoanal pressures during Valsalva maneuver and evacuation uncovers rectoanal discoordination in defecatory disorders	8
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids	8
Distinguishing the contributions of neuronal and mucosal serotonin in the regulation of colonic motility	8
Comparison of acid‐lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta‐Analysis	8
Role of inflammation in pediatric irritable bowel syndrome	8
Oral and parenteral anti‐neuropathic agents for the management of pain and discomfort in irritable bowel syndrome: A systematic review and meta‐analysis	8
Chronic stress increases DNA methylation of the GR promoter in the central nucleus of the amygdala of female rats	8
Metabolic syndrome is associated with higher rate of gastroesophageal reflux disease: a meta‐analysis	8
Same‐day opioid administration in opiate naïve patients is not associated with opioid‐induced esophageal dysfunction (OIED)	8
Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population	8
Autoantigen characterization in the lower esophageal sphincter muscle of patients with achalasia	8
Heterogeneity of primary and secondary peristalsis in systemic sclerosis: A new model of “scleroderma esophagus”	8
Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review	8
Milk coagulation and gastric emptying in women experiencing gastrointestinal symptoms after ingestion of cow's milk	8
The visceral sensitivity index: A novel tool for measuring GI‐symptom‐specific anxiety in inflammatory bowel disease	8
Gastroenterology Trainees’ Attitudes and Knowledge towards Patients with Disorders of Gut‐Brain Interaction	8
Prevalence and associated factors of disorders of gut‐brain interaction in the United States: Comparison of two nationwide Internet surveys	8
Timed barium swallow: Esophageal stasis varies markedly across subtypes of esophagogastric junction obstruction	8
Deep learning–based artificial intelligence model for identifying swallow types in esophageal high‐resolution manometry	8
Positive psychological well‐being: A novel concept for improving symptoms, quality of life, and health behaviors in irritable bowel syndrome	8
Pain in irritable bowel syndrome: Does anything really help?	8
Optimizing techniques for measuring anal resting and squeeze pressures with high‐resolution manometry	8
Gastrointestinal motility disorders in patients with multiple sclerosis: A single‐center study	8
Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis	7
The gut brain in a dish: Murine primary enteric nervous system cell cultures	7
Factors influencing rectal hypersensitivity in irritable bowel syndrome: A systematic review and meta‐analysis	7
Gastric electrical stimulation versus per‐oral pyloromyotomy for the treatment of nausea and vomiting associated with gastroparesis: An observational study of two cohorts	7
Estrogen and serotonin enhance stress‐induced visceral hypersensitivity in female rats by up‐regulating brain‐derived neurotrophic factor in spinal cord	7
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study	7
Barostat or syringe‐assisted sensory biofeedback training for constipation with rectal hyposensitivity: A randomized controlled trial	7
Dysphagia treatments in Parkinson's disease: A systematic review and meta‐analysis	7
Impact of ineffective esophageal motility on secondary peristalsis: Studies with high‐resolution manometry	7
13C‐gastric emptying breath tests: Clinical use in adults and children	7
A North American perspective on the ESNM consensus statement on gastroparesis	7
Cine gastric MRI reveals altered Gut–Brain Axis in Functional Dyspepsia: gastric motility is linked with brainstem‐cortical fMRI connectivity	7
Clinical characteristics and long‐term outcomes in patients with cyclic vomiting syndrome: A 15‐year experience at a tertiary referral center	7
Clinical efficacy and mechanism of transcutaneous neuromodulation on ineffective esophageal motility in patients with gastroesophageal reflux disease	7
Visible abdominal distension in functional gut disorders: Objective evaluation	7
Global patterns of prescription pain medication usage in disorders of gut–brain interactions	7
Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders	7
Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia	7
Stigma experiences of patients living with gastroparesis	7
Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation	7
Functional and anatomical gastric regions and their relations to motility control	7
COVID‐19–related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross‐sectional survey	7
Achalasia: Current therapeutic options	6
Fasted and fed small bowel motility patterns at cine‐MRI in chronic intestinal pseudo‐obstruction	6
Imperfect high‐resolution manometry studies: Prevalence and predictive factors	6
Efficacy of aprepitant as a prophylactic medication in adults with cyclic vomiting syndrome	6
Clinical features and long‐term outcomes in pediatric cyclic vomiting syndrome: A 9‐year experience at three tertiary academic centers	6
Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders	6
A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting	6
Effects of two different acute and subchronic stressors on gastrointestinal transit in the rat: A radiographic analysis	6
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation	6
Antroduodenal motility recording identifies characteristic patterns in gastroparesis related to underlying etiology	6
A pilot feasibility study of an unguided, internet‐delivered cognitive behavioral therapy program for irritable bowel syndrome	6
Placebo effects in functional dyspepsia: Causes and implications for clinical trials	6
Brain effect of transcutaneous vagal nerve stimulation: A meta‐analysis of neuroimaging evidence	6
Application of a RiboTag‐based approach to generate and analyze mRNA from enteric neural cells	6
Distinctive gastrointestinal motor dysfunction in patients with MNGIE	6
Fructose intolerance is not associated with malabsorption in patients with functional gastrointestinal disorders	6
Effect of phosphodiesterase‐4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model	6
Is the Sars‐CoV‐2 virus a possible trigger agent for the development of achalasia?	6
Erythropoietin promotes functional recovery in a mouse model of postoperative ileus	6
The impact of primary peristalsis, contractile reserve, and secondary peristalsis on esophageal clearance measured by timed barium esophagogram	6
Association between childhood constipation and exposure to stressful life events: a systematic review	6
TypeIIachalasia with focal elevated pressures: A distinct manometric and clinicalsub‐group	6
Glyphosate affects the neurochemical phenotype of the intramural neurons in the duodenum in the pig	6
Psychiatric comorbidities among adult patients with disorders of gut–brain interaction: Prevalence and relationships to treatment outcomes	6
Management of bloating	6
Metabotropic 5‐HT receptor‐mediated effects in the human submucous plexus	6
Diagnostic methods to measure spastic segment and guide tailored myotomy length in type 3 achalasia	6
Gastric electrical stimulation improves symptoms and need for supplemental nutrition in children with severe nausea and vomiting: A ten‐year experience	6
Validation and psychometric evaluation of the Spanish version of Brief Esophageal Dysphagia Questionnaire (BEDQ): Results of a multicentric study	6
Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia	6
Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease	6